Dengue Vaccine Performs Well in Small Clinical Trial

JAMA ◽  
2016 ◽  
Vol 315 (17) ◽  
pp. 1825 ◽  
Author(s):  
Tracy Hampton
2009 ◽  
Vol 5 (1) ◽  
pp. 33-40 ◽  
Author(s):  
Wellington Sun ◽  
Dennis Cunningham ◽  
Steven S. Wasserman ◽  
Judith Perry ◽  
J. Robert Putnak ◽  
...  

1994 ◽  
Vol 3 (2) ◽  
pp. 91-99 ◽  
Author(s):  
Michael J. Bohn ◽  
Henry R. Kranzler ◽  
Despina Beazoglou ◽  
Beth A. Staehler

BMJ ◽  
1986 ◽  
Vol 292 (6524) ◽  
pp. 899-900
Author(s):  
R A Dixon

BMJ ◽  
1986 ◽  
Vol 292 (6524) ◽  
pp. 899-899
Author(s):  
J. M. Thomas

2012 ◽  
Vol 19 (10) ◽  
pp. 1697-1699 ◽  
Author(s):  
Ellen S. Vitetta ◽  
Joan E. Smallshaw ◽  
John Schindler

ABSTRACTThere is no FDA-approved vaccine for the potent plant toxin ricin. We have developed a recombinant ricin vaccine, RiVax. Without adjuvant it is safe and immunogenic in mice, rabbits, and humans. Based on our studies in mice, we now report the results of a small clinical trial with Alhydrogel-adsorbed RiVax.


Thorax ◽  
1986 ◽  
Vol 41 (11) ◽  
pp. 822-823 ◽  
Author(s):  
R J Prescott

2009 ◽  
Vol 13 (06) ◽  
pp. 22-30

Situation of Chinese Medicine in China. World's First Tetravalent Dengue Vaccine in Clinical Trial.


1991 ◽  
Vol 12 (5) ◽  
pp. 706
Author(s):  
Scott D. Corley ◽  
Grace Ng ◽  
Mary Jo Gillespie

2015 ◽  
Vol 212 (7) ◽  
pp. 1032-1041 ◽  
Author(s):  
Sarah L. George ◽  
Mimi A. Wong ◽  
Tina J. T. Dube ◽  
Karen L. Boroughs ◽  
Janae L. Stovall ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document